These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 15276416)

  • 1. Understanding arsenic carcinogenicity by the use of animal models.
    Wanibuchi H; Salim EI; Kinoshita A; Shen J; Wei M; Morimura K; Yoshida K; Kuroda K; Endo G; Fukushima S
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):366-76. PubMed ID: 15276416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of 8-hydroxydeoxyguanosine and cell proliferation via generation of oxidative stress by organic arsenicals contributes to their carcinogenicity in the rat liver and bladder.
    Kinoshita A; Wanibuchi H; Wei M; Yunoki T; Fukushima S
    Toxicol Appl Pharmacol; 2007 Jun; 221(3):295-305. PubMed ID: 17481689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current progress in animal models of arsenic carcinogenesis].
    An Y
    Wei Sheng Yan Jiu; 2006 Nov; 35(6):814-8. PubMed ID: 17290776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of the sub-chronic toxic effects of three organic arsenical compounds on the urothelium in F344 rats; gender-based differences in response.
    Shen J; Wanibuchi H; Waalkes MP; Salim EI; Kinoshita A; Yoshida K; Endo G; Fukushima S
    Toxicol Appl Pharmacol; 2006 Feb; 210(3):171-80. PubMed ID: 15950995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds.
    Hirano S; Kobayashi Y; Cui X; Kanno S; Hayakawa T; Shraim A
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):458-67. PubMed ID: 15276427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic-induced bladder cancer in an animal model.
    Cohen SM; Ohnishi T; Arnold LL; Le XC
    Toxicol Appl Pharmacol; 2007 Aug; 222(3):258-63. PubMed ID: 17109909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative toxicity of arsenic metabolites in human bladder cancer EJ-1 cells.
    Naranmandura H; Carew MW; Xu S; Lee J; Leslie EM; Weinfeld M; Le XC
    Chem Res Toxicol; 2011 Sep; 24(9):1586-96. PubMed ID: 21815631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors.
    Wei M; Wanibuchi H; Morimura K; Iwai S; Yoshida K; Endo G; Nakae D; Fukushima S
    Carcinogenesis; 2002 Aug; 23(8):1387-97. PubMed ID: 12151359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment.
    Cohen SM; Arnold LL; Eldan M; Lewis AS; Beck BD
    Crit Rev Toxicol; 2006 Feb; 36(2):99-133. PubMed ID: 16736939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites.
    Kitchin KT
    Toxicol Appl Pharmacol; 2001 May; 172(3):249-61. PubMed ID: 11312654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver tumorigenicity of trimethylarsine oxide in male Fischer 344 rats--association with oxidative DNA damage and enhanced cell proliferation.
    Shen J; Wanibuchi H; Salim EI; Wei M; Kinoshita A; Yoshida K; Endo G; Fukushima S
    Carcinogenesis; 2003 Nov; 24(11):1827-35. PubMed ID: 12919961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells.
    Dopp E; Hartmann LM; Florea AM; von Recklinghausen U; Pieper R; Shokouhi B; Rettenmeier AW; Hirner AV; Obe G
    Toxicol Appl Pharmacol; 2004 Dec; 201(2):156-65. PubMed ID: 15541755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoting effects of monomethylarsonic acid, dimethylarsinic acid and trimethylarsine oxide on induction of rat liver preneoplastic glutathione S-transferase placental form positive foci: a possible reactive oxygen species mechanism.
    Nishikawa T; Wanibuchi H; Ogawa M; Kinoshita A; Morimura K; Hiroi T; Funae Y; Kishida H; Nakae D; Fukushima S
    Int J Cancer; 2002 Jul; 100(2):136-9. PubMed ID: 12115560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in C57BL6 mice following subchronic exposure to arsenate in drinking water.
    Kenyon EM; Hughes MF; Adair BM; Highfill JH; Crecelius EA; Clewell HJ; Yager JW
    Toxicol Appl Pharmacol; 2008 Nov; 232(3):448-55. PubMed ID: 18706920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiologically based pharmacokinetic modeling of arsenic in the mouse.
    Gentry PR; Covington TR; Mann S; Shipp AM; Yager JW; Clewell HJ
    J Toxicol Environ Health A; 2004 Jan; 67(1):43-71. PubMed ID: 14668111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of co-administration of antioxidants and arsenicals on the rat urinary bladder epithelium.
    Wei M; Arnold L; Cano M; Cohen SM
    Toxicol Sci; 2005 Feb; 83(2):237-45. PubMed ID: 15537745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal models for arsenic carcinogenesis: inorganic arsenic is a transplacental carcinogen in mice.
    Waalkes MP; Liu J; Ward JM; Diwan BA
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):377-84. PubMed ID: 15276417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trivalent arsenicals induce lipid peroxidation, protein carbonylation, and oxidative DNA damage in human urothelial cells.
    Wang TC; Jan KY; Wang AS; Gurr JR
    Mutat Res; 2007 Feb; 615(1-2):75-86. PubMed ID: 17134727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of inorganic arsenic on the rat and mouse urinary bladder.
    Suzuki S; Arnold LL; Ohnishi T; Cohen SM
    Toxicol Sci; 2008 Dec; 106(2):350-63. PubMed ID: 18728046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral exposure of dimethylarsinic acid, a main metabolite of inorganic arsenics, in mice leads to an increase in 8-Oxo-2'-deoxyguanosine level, specifically in the target organs for arsenic carcinogenesis.
    Yamanaka K; Takabayashi F; Mizoi M; An Y; Hasegawa A; Okada S
    Biochem Biophys Res Commun; 2001 Sep; 287(1):66-70. PubMed ID: 11549254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.